# Current Context

Latest checkpoint: `160_dual-agent-consensus-orchestration.md`
Progress: `160%`

## Compressed State

Expanded the repo workflow with a dual-agent consensus orchestrator that snapshots shared context, alternates proposal and review rounds between two agents, and only runs implementation, verification, and deployment hooks after consensus. The biomarker toolkit remains at the hardened 71-biomarker baseline with corrected catalog metadata and 49 passing tests.

## Locked Decisions

- Serum/plasma biomarkers also accept whole_blood specimen (generic Blood reporting)
- LOINC long-form aliases added for Synthea/EHR compatibility
- FHIR ingest auto-detected by .json extension
- Sample data excluded from git via .gitignore
- Blank-unit reference ranges are valid for unitless biomarkers and should be preserved
- Catalog LOINC edits require regression checks, not just spot inspection
- Dual-agent consensus runs from frozen context snapshots, not live mutable files
- Deploy hooks only run after one agent accepts the other agent's current proposal

## Immediate Next Steps

- Add real Codex and Claude wrapper scripts around the consensus tool
- Re-run large-sample validation after the 71-biomarker hardening pass
- Consider HL7v2 ingest for enterprise customers
- Add broader metadata sanity checks for future catalog expansion waves

## Resume From

Start from project_memory/current_context.md. The repo now includes a tested dual-agent consensus workflow plus the hardened 71-biomarker toolkit baseline. Next focus should be wiring real agent wrappers and continuing customer-driven validation and coverage expansion.
